Pictilisib Plus Anastrozole Reduces Proliferation in ER+ Breast Cancer
- PMID: 27012832
- DOI: 10.1158/2159-8290.CD-RW2016-055
Pictilisib Plus Anastrozole Reduces Proliferation in ER+ Breast Cancer
Abstract
The PI3K inhibitor pictilisib plus anastrozole suppresses luminal B breast cancer proliferation.
©2016 American Association for Cancer Research.
Comment on
-
Phase II Randomized Preoperative Window-of-Opportunity Study of the PI3K Inhibitor Pictilisib Plus Anastrozole Compared With Anastrozole Alone in Patients With Estrogen Receptor-Positive Breast Cancer.J Clin Oncol. 2016 Jun 10;34(17):1987-94. doi: 10.1200/JCO.2015.63.9179. Epub 2016 Mar 14. J Clin Oncol. 2016. PMID: 26976426 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
